Modulation of circulating cell-endothelial cell interaction by erythropoietin in lean and obese mice with cecal ligation and puncture

Pathophysiology

Volumn 17, Issue 1, 2010, Pages 9-18

  Vachharajani, Vidula ^a,c   Vital, Shantel ^a   Russell, Janice ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; Obesity; P selectin; Sepsis; TNF

Indexed keywords

ERYTHROPOIETIN; INFLIXIMAB; PADGEM PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CECUM; CELL INTERACTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; ENDOTHELIUM CELL; IMMUNOMODULATION; LEAN BODY WEIGHT; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SINGLE DRUG DOSE; THROMBOCYTE ADHESION;

EID: 73449134109     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.04.002     Document Type: Article

References (40)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., and Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29 (2001) 1303-1310
2. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
3. Satran R., and Almog Y. The coagulopathy of sepsis: pathophysiology and management. Isr. Med. Assoc. J. 5 (2003) 516-520
4. Marshall J.C., Cook D.J., Christou N.V., Bernard G.R., Sprung C.L., and Sibbald W.J. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23 (1995) 1638-1652
5. Sprung C.L., Peduzzi P.N., Shatney C.H., Schein R.M., Wilson M.F., Sheagren J.N., and Hinshaw L.B. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit. Care Med. 18 (1990) 801-806
6. Corwin H.L., Gettinger A., Fabian T.C., May A., Pearl R.G., Heard S., An R., Bowers P.J., Burton P., Klausner M.A., et al. Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med. 357 (2007) 965-976
7. Krafte-Jacobs B., and Bock G.H. Circulating erythropoietin and interleukin-6 concentrations increase in critically ill children with sepsis and septic shock. Crit. Care Med. 24 (1996) 1455-1459
8. Cuzzocrea S., Di Paola R., Mazzon E., Patel N.S., Genovese T., Muia C., Crisafulli C., Caputi A.P., and Thiemermann C. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice. Crit. Care Med. 34 (2006) 1168-1177
9. Abdelrahman M., Sharples E.J., McDonald M.C., Collin M., Patel N.S., Yaqoob M.M., and Thiemermann C. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 22 (2004) 63-69
10. Allison D.B., Fontaine K.R., Manson J.E., Stevens J., and VanItallie T.B. Annual deaths attributable to obesity in the United States. JAMA 282 (1999) 1530-1538
11. Huang Z., Willett W.C., Manson J.E., Rosner B., Stampfer M.J., Speizer F.E., and Colditz G.A. Body weight, weight change, and risk for hypertension in women. Ann. Intern. Med. 128 (1998) 81-88
12. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., and Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162 (2002) 1867-1872
13. Bercault N., Boulain T., Kuteifan K., Wolf M., Runge I., and Fleury J.C. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit. Care Med. 32 (2004) 998-1003
14. Yaegashi M., Jean R., Zuriqat M., Noack S., and Homel P. Outcome of morbid obesity in the intensive care unit. J. Intensive Care Med. 20 (2005) 147-154
15. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., Steingrub J.S., Garber G.E., Helterbrand J.D., Ely E.W., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
16. van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., and Bouillon R. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 345 (2001) 1359-1367
17. Morris A.E., Stapleton R.D., Rubenfeld G.D., Hudson L.D., Caldwell E., and Steinberg K.P. The association between body mass index and clinical outcomes in acute lung injury. Chest 131 (2007) 342-348
18. Vachharajani V., Russell J.M., Scott K.L., Conrad S., Stokes K.Y., Tallam L., Hall J., and Granger D.N. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation 12 (2005) 183-194
19. Vachharajani V., Vital S., Russell J., Scott L.K., and Granger D.N. Glucocorticoids inhibit the cerebral microvascular dysfunction associated with sepsis in obese mice. Microcirculation 13 (2006) 477-487
20. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., Rustenbeck H.H., Breiter N., Jacob S., Knerlich F., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8 (2002) 495-505
21. Kao R., Xenocostas A., Rui T., Yu P., Huang W., Rose J., and Martin C.M. Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit. Care 11 (2007) R58
22. Bauer P., Lush C.W., Kvietys P.R., Russell J.M., and Granger D.N. Role of endotoxin in the expression of endothelial selectins after cecal ligation and perforation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278 (2000) R1140-R1147
23. Ishikawa M., Cooper D., Russell J., Salter J.W., Zhang J.H., Nanda A., and Granger D.N. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 34 (2003) 1777-1782
24. Tailor A., and Granger D.N. Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 675-680
25. Cerwinka W.H., Cooper D., Krieglstein C.F., Ross C.R., McCord J.M., and Granger D.N. Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H535-H541
26. Tsujikawa A., Kiryu J., Yamashiro K., Nonaka A., Nishijima K., Honda Y., and Ogura Y. Interactions between blood cells and retinal endothelium in endotoxic sepsis. Hypertension 36 (2000) 250-258
27. Esen F., Erdem T., Aktan D., Orhan M., Kaya M., Eraksoy H., Cakar N., and Telci L. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Crit. Care 9 (2005) R18-R23
28. Berridge C.W., and Dunn A.J. Corticotropin-releasing factor elicits naloxone sensitive stress-like alterations in exploratory behavior in mice. Regul. Pept. 16 (1986) 83-93
29. Eppihimer M.J., Wolitzky B., Anderson D.C., Labow M.A., and Granger D.N. Heterogeneity of expression of E- and P-selectins in vivo. Circ. Res. 79 (1996) 560-569
30. Eppihimer M.J., Russell J., Anderson D.C., Wolitzky B.A., and Granger D.N. Endothelial cell adhesion molecule expression in gene-targeted mice. Am. J. Physiol. 273 (1997) H1903-H1908
31. Panes J., Perry M.A., Anderson D.C., Manning A., Leone B., Cepinskas G., Rosenbloom C.L., Miyasaka M., Kvietys P.R., and Granger D.N. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. J. Physiol. 269 (1995) H1955-H1964
32. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Patel N.S., Britti D., de Majo M., Caputi A.P., and Thiemermann C. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Arthritis Rheum. 52 (2005) 940-950
33. Grounds M.D., Davies M., Torrisi J., Shavlakadze T., White J., and Hodgetts S. Silencing TNFalpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res. 320 (2005) 509-515
34. Liu X., Xie W., Liu P., Duan M., Jia Z., Li W., and Xu J. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci. 78 (2006) 2255-2264
35. Riabov S.I., Shostka G.D., Petrova N.N., Vasil'eva I.A., and Vasil'ev A.N. The effect of Recormon therapy on the quality of life of patients on hemodialysis treatment. Ter. Arkh. 68 (1996) 43-46
36. Zhang H., Zhi L., Moochhala S.M., Moore P.K., and Bhatia M. Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J. Leukoc. Biol. 82 (2007) 894-905
37. Kopp H.P., Kopp C.W., Festa A., Krzyzanowska K., Kriwanek S., Minar E., Roka R., and Schernthaner G. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1042-1047
38. Essani N.A., Fisher M.A., Simmons C.A., Hoover J.L., Farhood A., and Jaeschke H. Increased P-selectin gene expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxin shock. J. Leukoc. Biol. 63 (1998) 288-296
39. Minagar A., and Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9 (2003) 540-549
40. Russell J., Cooper D., Tailor A., Stokes K.Y., and Granger D.N. Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G123-G129